At the University of British Columbia, the Blakney Lab is focused on developing vaccines and therapies using self-amplifying ...

Moderna stock crumbled Thursday after the biotech company missed sales estimates for its two products, Spikevax and mResvia.

Biotechnology company Moderna (NASDAQ:MRNA) in Q1 CY2025, with sales falling 35.3% year on year to $108 million. The ...